|
1
|
Ford JR, Rubin ML, Frank SJ, Ning J,
Debnam JM, Bell D, El-Naggar A, Ferrarotto R and Esmaeli B:
Prognostic factors for local recurrence and survival and impact of
local treatments on survival in lacrimal gland carcinoma. Br J
Ophthalmol. Jul 17–2020.(Epub ahead of print). doi:
10.1136/bjophthalmol-2020-316142. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sharma K, Rathi A, Khurana N, Mukherji A,
Kumar V, Singh K and Bahadur AK: A retrospective study of 18 cases
of adenoid cystic cancer at a tertiary care centre in Delhi. Indian
J Cancer. 47:424–429. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen TY, Keeney MG, Chintakuntlawar AV,
Knutson DL, Kloft-Nelson S, Greipp PT, Garrity JA, Salomao DR and
Garcia JJ: Adenoid cystic carcinoma of the lacrimal gland is
frequently characterized by MYB rearrangement. Eye (Lond).
31:720–725. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Esmaeli B, Ahmadi M, Youssef A, Diba R,
Amato M, Myers JN, Kies M and El-Naggar A: Outcomes in patients
with adenoid cystic carcinoma of the lacrimal gland. Ophthalmic
Plast Reconstr Surg. 20:22–26. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wolkow N, Jakobiec F and Lee H: Long-term
outcomes of globe-preserving surgery with proton beam radiation for
adenoid cystic carcinoma of lacrimal gland. Am J Ophthalmol.
201:84–85. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Han J, Kim Y, Woo K and Sobti D: Long-term
outcomes of eye-sparing surgery for adenoid cystic carcinoma of
lacrimal gland. Ophthalmic Plast Reconstr Surg. 34:74–78. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Snyder M and Paulino A: Hybrid carcinoma
of the salivary gland: Salivary duct adenocarcinoma adenoid cystic
carcinoma. Histopathology. 35:380–383. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nagao T: ‘Dedifferentiation’ and
high-grade transformation in salivary gland carcinomas. Head Neck
Pathol. 7 (Suppl 1):S37–S47. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kamio N, Tanaka Y, Mukai M, Ikeda E,
Kuramochi S, Fujii M and Hosoda Y: A hybrid carcinoma: Adenoid
cystic carcinoma and salivary duct carcinoma of the salivary gland.
Virchows Archiv. 430:495–500. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nagao T, Gaffey TA, Serizawa H, Sugano I,
Ishida Y, Yamazaki K, Tokashiki R, Yoshida T, Minato H, Kay PA and
Lewis JE: Dedifferentiated adenoid cystic carcinoma: A
clinicopathologic study of 6 cases. Mod Pathol. 16:1265–1272. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
White VA: Update on lacrimal gland
neoplasms: Molecular pathology of interest. Saudi J Ophthalmol.
26:133–135. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pusztaszeri M and Brochu V: Metastatic
adenoid cystic carcinoma with high-grade transformation
(‘dedifferentiation’) in pleural effusion and neck lymph node: A
diagnostic challenge on cytology? Diagn Cytopathol. 48:679–683.
2020. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Panni S, Lovering RC, Porras P and Orchard
S: Non-coding RNA regulatory networks. Biochim Biophys Acta Gene
Regul Mech. 1863:1944172020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang M, Zhang J, Zhang H and Tang H:
miR-24-3p suppresses malignant behavior of lacrimal adenoid cystic
carcinoma by targeting PRKCH to regulate p53/p21 pathway. PLoS One.
11:e01584332016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hao J, Jin X, Shi Y and Zhang H: miR-93-5p
enhance lacrimal gland adenoid cystic carcinoma cell tumorigenesis
by targeting BRMS1L. Cancer Cell Int. 18:722018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Salzman J: Circular RNA expression: Its
potential regulation and function. Trends Genet. 32:309–316. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Salmena L, Poliseno L, Tay Y, Kats L and
Pandolfi P: A ceRNA hypothesis: The Rosetta stone of a hidden RNA
language? Cell. 146:353–358. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Smillie CL, Sirey T and Ponting CP:
Complexities of post-transcriptional regulation and the modeling of
ceRNA crosstalk. Crit Rev Biochem Mol Biol. 53:231–245. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lin T, Zhu L, Zhou B, Xie L, Lv J, Dong L
and He Y: Establishment and characterization of a cell line from
human adenoid cystic carcinoma of the lacrimal glands and a nude
mouse transplantable model. Oncol Rep. 33:2797–2806. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gao R, Cao C, Zhang M, Lopez MC, Yan Y,
Chen Z, Mitani Y, Zhang L, Zajac-Kaye M, Liu B, et al: A unifying
gene signature for adenoid cystic cancer identifies parallel
MYB-dependent and MYB-independent therapeutic targets. Oncotarget.
5:12528–12542. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kumar G, Kumar R, Pal MK, Pramanik N,
Lahiri T, Gupta A and Pandey S: APT: An Automated Probe Tracker
from gene expression data. IEEE/ACM Trans Comput Biol Bioinform.
Dec 9–2019.(Epub ahead of print). doi: 10.1109/TCBB.2019.2958345.
View Article : Google Scholar
|
|
22
|
Kim B: How to reveal magnitude of gene
signals: Hierarchical hypergeometric complementary cumulative
distribution function. Evol Bioinform Online.
14:11769343187973522018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dudekula DB, Panda AC, Grammatikakis I, De
S, Abdelmohsen K and Gorospe M: CircInteractome: A web tool for
exploring circular RNAs and their interacting proteins and
microRNAs. RNA Biol. 13:34–42. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Szklarczyk D, Gable AL, Lyon D, Junge A,
Wyder S, Huerta-Cepas J, Simonovic M, Doncheva NT, Morris JH, Bork
P, et al: STRING v11: Protein-protein association networks with
increased coverage, supporting functional discovery in genome-wide
experimental datasets. Nucleic Acids Res. 47:D607–D613. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Savithri V, Suresh R, Janardhanan M,
Aravind T and Mohan M: Primary intraosseous adenoid cystic
carcinoma with widespread skeletal metastases showing features of
high-grade transformation. Head Neck Pathol. Sep 21–2020.(Epub
ahead of print). doi: 10.1007/s12105-020-01228-x. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Falzone L, Grimaldi M, Celentano E,
Augustin L and Libra M: Identification of modulated MicroRNAs
associated with breast cancer, diet, and physical activity.
Cancers. 12:25552020. View Article : Google Scholar
|
|
29
|
Filetti V, Falzone L, Rapisarda V,
Caltabiano R, Eleonora Graziano AC, Ledda C and Loreto C:
Modulation of microRNA expression levels after naturally occurring
asbestiform fibers exposure as a diagnostic biomarker of
mesothelial neoplastic transformation. Ecotoxicol Environ Saf.
198:1106402020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liu Y, Di G, Hu S, Zhao T, Xu X, Wang X
and Chen P: Expression profiles of CircRNA and mRNA in lacrimal
glands of AQP5 mice with primary dry eye. Front Physiol.
11:10102020. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Han D, Li J, Wang H, Su X, Hou J, Gu Y,
Qian C, Lin Y, Liu X, Huang M, et al: Circular RNA circMTO1 acts as
the sponge of microRNA-9 to suppress hepatocellular carcinoma
progression. Hepatology. 66:1151–1164. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hansen TB, Jensen TI, Clausen BH, Bramsen
JB, Finsen B, Damgaard CK and Kjems J: Natural RNA circles function
as efficient microRNA sponges. Nature. 495:384–388. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Nakaguro M, Faquin WC, Baloch ZW, Cantley
RL, Compton ML, Ely KA, Holmes BJ, Hu R, Kerr DA, Montone KT, et
al: Fine needle aspiration of salivary gland carcinomas with
high-grade transformation: A multi-institutional study of 22 cases
and review of the literature. Cancer Cytopathol. Nov 19–2020.(Epub
ahead of print). doi: 10.1002/cncy.22388. View Article : Google Scholar
|
|
34
|
Seethala R and Stenman G: Update from the
4th Edition of the World Health Organization Classification of Head
and Neck Tumours: Tumors of the salivary gland. Head Neck Pathol.
11:55–67. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Seethala R, Hunt J, Baloch Z, Livolsi V
and Leon Barnes E: Adenoid cystic carcinoma with high-grade
transformation: A report of 11 cases and a review of the
literature. Am J Surg Pathol. 31:1683–1694. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kiss O, Tőkés A, Spisák S, Szilágyi A,
Lippai N, Székely B, Szász AM and Kulka J: Breast- and salivary
gland-derived adenoid cystic carcinomas: potential
post-transcriptional divergencies. A pilot study based on miRNA
expression profiling of four cases and review of the potential
relevance of the findings. Pathol Oncol Res. 21:29–44. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhai H, Fesler A, Ba Y, Wu S and Ju J:
Inhibition of colorectal cancer stem cell survival and invasive
potential by hsa-miR-140-5p mediated suppression of Smad2 and
autophagy. Oncotarget. 6:19735–19746. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Salem O, Erdem N, Jung J, Münstermann E,
Wörner A, Wilhelm H, Wiemann S and Körner C: The highly expressed
5′isomiR of hsa-miR-140-3p contributes to the tumor-suppressive
effects of miR-140 by reducing breast cancer proliferation and
migration. BMC Genomics. 17:5662016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Joerger A and Fersht A: The p53 pathway:
Origins, inactivation in cancer, and emerging therapeutic
approaches. Ann Rev Biochem. 85:375–404. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Sanchez-Vega F, Mina M, Armenia J, Chatila
WK, Luna A, La KC, Dimitriadoy S, Liu DL, Kantheti HS, Saghafinia
S, et al: Oncogenic signaling pathways in the cancer genome atlas.
Cell. 173:321–337.e10. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Tang C and Zhu G: Classic and novel
signaling pathways involved in cancer: Targeting the NF-κB and Syk
signaling pathways. Curr Stem Cell Res Ther. 14:219–225. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Guo Y, Pan W, Liu S, Shen Z, Xu Y and Hu
L: ERK/MAPK signalling pathway and tumorigenesis. Exp Ther Med.
19:1997–2007. 2020.PubMed/NCBI
|
|
43
|
Park IA, Hwang SH, Song IH, Heo SH, Kim
YA, Bang WS, Park HS, Lee M, Gong G and Lee HJ: Expression of the
MHC class II in triple-negative breast cancer is associated with
tumor-infiltrating lymphocytes and interferon signaling. PLoS One.
12:e01827862017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Joo CH, Shin YC, Gack M, Wu L, Levy D and
Jung JU: Inhibition of interferon regulatory factor 7
(IRF7)-mediated interferon signal transduction by the Kaposi's
sarcoma-associated herpesvirus viral IRF homolog vIRF3. J Virol.
81:8282–8292. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Slattery M, Lundgreen A, Bondurant K and
Wolff R: Interferon-signaling pathway: Associations with colon and
rectal cancer risk and subsequent survival. Carcinogenesis.
32:1660–1667. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Falzone L, Romano GL, Salemi R, Bucolo C,
Tomasello B, Lupo G, Anfuso CD, Spandidos DA, Libra M and Candido
S: Prognostic significance of deregulated microRNAs in uveal
melanomas. Mol Med Rep. 19:2599–2610. 2019.PubMed/NCBI
|
|
47
|
Wei D, Wang W, Shen B, Zhou Y, Yang X, Lu
G, Yang J and Shao Y: MicroRNA-199a-5p suppresses migration and
invasion in oral squamous cell carcinoma through inhibiting the
EMT-related transcription factor SOX4. Int J Mol Med. 44:185–195.
2019.PubMed/NCBI
|
|
48
|
Zhang C, Chen Q, Zhu J and Liu Z:
MicroRNA-199a-5p regulates glioma progression via targeting MARCH8.
Eur Rev Med Pharmacol Sci. 23:7482–7487. 2019.PubMed/NCBI
|
|
49
|
Ahmadi A, Khansarinejad B, Hosseinkhani S,
Ghanei M and Mowla S: miR-199a-5p and miR-495 target GRP78 within
UPR pathway of lung cancer. Gene. 620:15–22. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Wang C, Qi S, Xie C, Li C, Wang P and Liu
D: Upregulation of long non-coding RNA XIST has anticancer effects
on epithelial ovarian cancer cells through inverse downregulation
of hsa-miR-214-3p. J Gynecol Oncol. 29:e992018. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Sun X, Huang T, Zhang C, Zhang S, Wang Y,
Zhang Q and Liu Z: Long non-coding RNA LINC00968 reduces cell
proliferation and migration and angiogenesis in breast cancer
through up-regulation of PROX1 by reducing hsa-miR-423-5p. Cell
Cycle. 18:1908–1924. 2019. View Article : Google Scholar : PubMed/NCBI
|
